Overview Fundamentals API Earnings EOD API Sample Code Pricing

Aquestive Therapeutics Inc (AQST NASDAQ) stock market data APIs

$4.63 -0.18(-3.7%) as of November 25, 2024
Price chart is built with Anychart

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. The company's proprietary pipeline of complex molecule product includes AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and Anaphylm, an epinephrine sublingual film for the emergency treatment of allergic reactions, including anaphylaxis. In addition, it develops Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Aquestive Therapeutics Inc Financial Data Overview

4.81
4.63
-
4.84
4.545
1.84-6.23
439 M
91 178 K
58 900 K
-0.13
2.816
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AQST',
Type: 'Common Stock',
Name: 'Aquestive Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00L9HP0Z0',
ISIN: NULL,
CUSIP: NULL,
CIK: '1398733',
EmployerIdNumber: '82-3827296',
FiscalYearEnd: 'December',
IPODate: '2018-07-25',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Aquestive Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 58 900 K
  • EBITDA -20 038 000
  • Earnings Per Share -0.48
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Aquestive Therapeutics Inc Earnings via APIs

  • Latest Release 2024-11-04
  • EPS/Forecast -0.13

Get Aquestive Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com